長庚醫療財團法人林口長庚紀念醫院是成立於1978年12月1日的私立綜合醫院。到2019年底為止，林口長庚紀念醫院是全世界床位數第二多的醫院。

During the past decade, Chang Gung Memorial Hospital, Linkou conducted 276 clinical trials. In the 10-year time frame, 276 clinical trials started and 53 clinical trials were completed, i.e. on average, 19.2% percent of trials that started reached the finish line to date. In the past 5 years, 139 clinical trials started and 50 clinical trials were completed. i.e. 36% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chang Gung Memorial Hospital, Linkou" #1 sponsor was "Chang Gung Memorial Hospital" with 43 trials, followed by "Janssen Research & Development, LLC" with 21 trials sponsored, "Pfizer" with 15 trials sponsored, "Eli Lilly and Company" with 11 trials sponsored and "Amgen" with 11 trials sponsored. Other sponsors include 203 different institutions and companies that sponsored additional 121 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chang Gung Memorial Hospital, Linkou" #1 collaborator was "Chang Gung Memorial Hospital" with 17 trials as a collaborator, "National Cheng-Kung University Hospital" with 9 trials as a collaborator, "National Taiwan University Hospital" with 9 trials as a collaborator, "Taipei Veterans General Hospital, Taiwan" with 8 trials as a collaborator and "China Medical University Hospital" with 7 trials as a collaborator. Other collaborators include 138 different institutions and companies that were collaborators in the rest 107 trials.

According to Clinical.Site data, the most researched conditions in "Chang Gung Memorial Hospital, Linkou" are "Alzheimer's Disease" (9 trials), "Atopic Dermatitis" (8 trials), "Breast Cancer" (5 trials), "Hepatocellular Carcinoma" (5 trials) and "Nasopharyngeal Carcinoma" (5 trials). Many other conditions were trialed in "Chang Gung Memorial Hospital, Linkou" in a lesser frequency.

Most popular intervention types in "Chang Gung Memorial Hospital, Linkou" are "Drug" (228 trials), "Biological" (32 trials), "Device" (24 trials), "Other" (22 trials) and "Behavioral" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (65 trials), "Cisplatin" (8 trials), "Pembrolizumab" (8 trials), "Docetaxel" (7 trials) and "Gemcitabine" (7 trials). Other intervention names were less common.

The vast majority of trials in "Chang Gung Memorial Hospital, Linkou" are 278 trials for "All" genders, 16 trials for "Female" genders and 14 trials for "Male" genders.

Currently, there are 147 active trials in "Chang Gung Memorial Hospital, Linkou". 2 are not yet recruiting, 77 are recruiting, 59 are Active, not recruiting, and 9 are Enrolling by invitation. In total, there were 110 completed trials in Chang Gung Memorial Hospital, Linkou, 1 suspended trials, and 29 terminated clinical trials to date.

Out of the total trials that were conducted in Chang Gung Memorial Hospital, Linkou, 32 "Phase 1" clinical trials were conducted, 90 "Phase 2" clinical trials and 127 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 30 trials that are defined as “Not Applicable".